Average Co-Inventor Count = 5.16
ph-index = 47
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Dharmacon, Inc. (111 from 115 patents)
2. University of Massachusetts (34 from 1,524 patents)
3. Thermo Fisher Scientific Gmbh (16 from 128 patents)
4. Rxi Pharmaceuticals Corporation (15 from 16 patents)
5. Phio Pharmaceuticals Corp. (14 from 22 patents)
6. Ge Healthcare Dharmacon, Inc. (5 from 9 patents)
7. Beth Israel Deaconess Medical Center, Inc. (4 from 510 patents)
8. Thermo Fisher Scientific Biosciences Inc. (4 from 6 patents)
9. Merck & Company, Inc. (1 from 4,759 patents)
10. University Technology Corporation (1 from 80 patents)
11. Elitech Holding B.v. (1 from 19 patents)
12. Elitechgroup B.v. (1 from 9 patents)
13. Rxi Parmaceuticals Corporation (1 from 1 patent)
202 patents:
1. 12365894 - Branched lipid conjugates of siRNA for specific tissue delivery
2. 12344839 - Dual-acting siRNA based modulation of C9orf72
3. 12297430 - O-methyl rich fully stabilized oligonucleotides
4. 12258566 - Oligonucleotides for PRNP modulation
5. 12180477 - Dynamic pharmacokinetic-modifying anchors
6. 12173286 - Fully stabilized asymmetric siRNA
7. 12146136 - Synthesis of modified oligonucleotides with increased stability
8. 12077755 - Bioactive conjugates for oligonucleotide delivery
9. 12077758 - Oligonucleotides for SARS-CoV-2 modulation
10. 12049627 - Two-tailed self-delivering siRNA
11. 12037585 - Oligonucleotides for tissue specific gene expression modulation
12. 12023407 - Artificial exosome composition and related methods
13. 12024706 - Modified oligonucleotides targeting SNPs
14. 11896669 - Branched oligonucleotides
15. 11827882 - Modified oligonucleotides targeting SNPs